It has been reported that HDAC inhibitors synergize with 5-FU invitro and in vivo to treat colon cancer throughdownregulation of thymidylate synthase, the 5-FU target enzyme [46]. This evidence concerns the gene HDAC9 and malignant colon neoplasm.